Generic Industry Wants US FDA To Consider Allowing Foreign Reference Products For ANDAs

 
• By Derrick Gingery
  
Global strategy solution concept - earth jigsaw puzzle
Allowing bridging of US and foreign reference standards could lower generic drug development costs, the industry argues. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics